SCHEMBL2811449

SCHEMBL2811449

O=C(Nc1ccccc1)/C(=C\Sc1ccccc1)Sc1ccccc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 7/20 0.43
KMT2A Q03164 5/20 0.43
MEN1 O00255 4/20 0.43
POLB P06746 2/20 0.43
MAPT P10636 2/20 0.43
MAPK1 P28482 2/20 0.43
TP53 P04637 2/20 0.43
HSD17B10 Q99714 2/20 0.43
KDM4E B2RXH2 2/20 0.41
LMNA P02545 2/20 0.41
ALDH1A1 P00352 1/20 0.41
HPGD P15428 1/20 0.41
HTT P42858 1/20 0.41
EPHX1 P07099 1/20 0.41
TSHR P16473 1/20 0.41
EPHX2 P34913 1/20 0.41
CDK9 P50750 1/20 0.41
CLK4 Q9HAZ1 1/20 0.41
RAB9A P51151 6/20 0.40
L3MBTL1 Q9Y468 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12851365 1.00 SMN1; SMN2 (0.43) SMN1; SMN2KMT2AMEN1POLBMAPT
SCHEMBL2811451 1.00 SMN1; SMN2 (0.43) SMN1; SMN2KMT2AMEN1POLBMAPT
SCHEMBL2808862 0.92 NPC1 (0.44) SMN1; SMN2KMT2AMEN1POLBMAPT
SCHEMBL2808865 0.92 NPC1 (0.44) SMN1; SMN2KMT2AMEN1POLBMAPT
SCHEMBL2813368 0.87 SMN1; SMN2 (0.46) SMN1; SMN2KMT2AMEN1POLBMAPT
SCHEMBL2813369 0.87 SMN1; SMN2 (0.46) SMN1; SMN2KMT2AMEN1POLBMAPT
SCHEMBL12878516 0.79 MTNR1A (0.37) SMN1; SMN2KMT2AMEN1POLBMAPT
SCHEMBL2812825 0.79 ALDH1A1 (0.43) SMN1; SMN2KMT2AMEN1MAPTHSD17B10
SCHEMBL2812828 0.79 ALDH1A1 (0.43) SMN1; SMN2KMT2AMEN1MAPTHSD17B10
SCHEMBL2812834 0.79 HSD17B10 (0.53) SMN1; SMN2KMT2AMEN1POLBMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8278473-B2 Alpha, beta-unsaturated imidate compound and pesticidal composition containing the same SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2012-10-02 US disclosed
US-20100240729-A1 ALPHA, BETA-UNSATURATED IMIDATE COMPOUND AND PESTICIDAL COMPOSITION CONTAINING THE SAME SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2010-09-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100240729-A1 ALPHA, BETA-UNSATURATED IMIDATE COMPOUND AND PESTICIDAL COMPOSITION CONTAINING THE SAME OXER1, CBR1, DEGS1 SMN1; SMN2 1135/4885KMT2A 3324/4885MEN1 3112/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.